Merck Announces Foundry DevTools Data Library is Now Free on Github
Merck KGaA has announced that its Foundry DevTools library, created with Palantir Technologies, will be freely available to users on Github, an open-source repository of code and software development resources. Merck and other pharma giants have used the platform for drug development and real-world evidence (RWE) analysis. This move marks a first for the platform.
Nature Medicine Perspective: Next-Gen Evidence-Based Medicine
The recent wave of digital health solutions, data analytics, and artificial intelligence (AI) is driving the newest generation of evidence-based medicine, according to a Nature Medicine perspective by Vivek Subbiah. These technologies are empowering novel clinical trials that utilize real-world evidence (RWE) and patient-centric approaches in a wide range of fields and disease contexts.
AJMC View: Balancing Cancer Treatment Innovation and Economic Burden
At The American Journal of Managed Care’s Institute for Value-Based Medicine event that took place this past October, speakers discussed the high cost of new therapeutics. A balance must be struck, according to Kevin Cohen, MD, of Optum Care, using data analytics to optimize care quality and costs.
Interview with Nasim Asfar, Chief Health Officer of Oracle Health
Chief Healthcare Executive has published a new interview with Nasim Asfar, Oracle Health’s Chief Health Officer. Asfar is spearheading efforts to target health disparities to support health equity efforts and how Oracle Health is using tech to do so. She starts by touching on the outsized importance of social determinants of health (SDoH).
Accession Digital Platform Hits 7-Year Development Milestone
Accession has announced that its digital platform pathwaypro® has hit 7 years of product development, completing a major goal set by the company 7 years ago. The platform allows healthcare organizations and decision-makers to model drug optimization and value-assessment. In a recent annual ranking of pharma companies in the UK, Accession was rated “one to watch”.
Global Pricing Innovations Launches GPI Horizon Platform for Value Assessment
Global Pricing Innovations (GPI) has announced the launch of its new GPI Horizon platform. GPI Horizon is an analytics-based tool to expedite value-assessment and price prediction across the entire life cycle to help drive market access and reduce payer risk. The program is part of GPI’s larger offerings, but can be used in a self-service model.
Natalie Douglas and Patti Peeples Join Global Pricing Innovations Board of Directors
Global Pricing Innovations (GPI) has announced that Natalie Douglas and Patti Peeples, PhD, will join the company’s board of directors. Douglas, who will join as the new Chair, is the founder of RealiTi Health and serves as a strategic advisor for GPI. Peeples is the founder and former CEO of HealthEconomics.com, and is a leading voice of the health economics and outcomes research (HEOR) community.
Researchers Put Forward New Healthcare Data Use Framework
A group of researchers from around the world have proposed a new framework for the use of healthcare data in research. The framework, published in several journals, guides researchers in several aspects of healthcare usage, such as transparency, quality assessment, and more. The team constructing the framework consisted of stakeholders from healthcare, government, research, and patient advocacy groups
Addressing Healthcare Data Sovereignty with Synthetic Data
Real-world data (RWD) sources are used across the world but are governed by their origin countries, which often have different legal frameworks than the nation they are used in. These conflicts over “data sovereignty,” as it is called, hold back research and development and create international issues of patient privacy. A potential path forward is the use of synthetic data, simulated data based on existing datasets.
